|
Market Closed -
Nasdaq
16:00:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 25.67 USD | +4.78% |
|
+5.94% | -7.40% |
| 09-09 | Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01:00 PM | |
| 09-08 | Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints | DJ |
| Market Cap | 2.57B 2.29B 2.13B 1.94B 3.65B 247B 3.68B 25.76B 10.02B 126B 9.63B 9.42B 405B | P/E 2026 * |
-5.81x | P/E 2027 * | -5.38x |
|---|---|---|---|---|---|
| Enterprise Value | 1.65B 1.47B 1.37B 1.25B 2.35B 159B 2.37B 16.56B 6.44B 81.04B 6.19B 6.06B 260B | EV / Sales 2026 * |
33.9x | EV / Sales 2027 * | 21.4x |
| Free-Float |
98.75% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BEAM | Delayed | |
CBOE
| BEAM | Real-time | |
|
Mexican S.E.
| BEAM * | End-of-day quote |
Last Transcript: Beam Therapeutics Inc.
| 1 day | +4.78% | ||
| 1 week | +5.94% | ||
| Current month | +4.99% | ||
| 1 month | -13.45% | ||
| 3 months | -26.21% | ||
| 6 months | +4.10% | ||
| Current year | -7.40% |
| 1 week | 23.83 |  | 26.04 |
| 1 month | 22.67 | | 27.3 |
| Current year | 21.63 | | 38.26 |
| 1 year | 20.23 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 100.06 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 2016-12-31 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 2024-12-18 |
| President | 57 | 2020-01-23 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 2016-12-31 |
Mark Fishman
BRD | Director/Board Member | 75 | 2018-04-30 |
Graham Cooper
BRD | Director/Board Member | 56 | 2019-10-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Sell | Controller/Auditor | -187 | 0.0002% | ||
| 9/24/26 | Don | Chairperson | -123,407 | 0.1195% | ||
| 7/27/26 | Sell | Chief Technology Officer | -16,667 | 0.0162% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.78% | +5.94% | -0.31% | +15.32% | 2.45B | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.81% | +19.75% | +78.12% | 57.39B | |
| +1.63% | -1.61% | +3.83% | +36.89% | 47.64B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.29B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 42.5B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 40.71B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 30.97B | |
| +1.56% | +3.75% | +31.34% | +29.14% | 28.53B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.34B | |
| Average | +1.65% | +0.47% | +48.44% | +117.00% | 39.3B | |
| Weighted average by Cap. | +1.57% | -0.37% | +57.70% | +136.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48.57M 43.33M 40.37M 36.74M 69.18M 4.68B 69.7M 488M 190M 2.39B 182M 178M 7.67B | 62.75M 55.98M 52.15M 47.46M 89.38M 6.04B 90.04M 630M 245M 3.08B 236M 230M 9.91B |
| Net income | -462M -412M -384M -349M -658M -44.48B -663M -4.64B -1.8B -22.7B -1.73B -1.7B -72.97B | -537M -479M -446M -406M -764M -51.67B -770M -5.39B -2.1B -26.37B -2.01B -1.97B -84.78B |
| Net Debt | -916M -817M -762M -693M -1.31B -88.25B -1.31B -9.2B -3.58B -45.04B -3.44B -3.37B -145B | -1.22B -1.09B -1.02B -924M -1.74B -118B -1.75B -12.27B -4.77B -60.05B -4.59B -4.49B -193B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-05 | US$25.67 | +4.78% | 1,999,857 |
| 26-10-02 | US$24.50 | +0.45% | 1,498,573 |
| 26-10-01 | US$24.39 | -0.25% | 1,695,437 |
| 26-09-30 | US$24.45 | -0.29% | 1,559,294 |
| 26-09-29 | US$24.52 | +1.20% | 1,637,524 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
